Department of Medical Genetics, National Taiwan University Hospital, No. 8, Chung-Shan S. Rd., Zhongzheng Dist., Taipei, 10041, Taiwan.
Department of Pediatrics, National Taiwan University Hospital, No. 8, Chung-Shan S. Rd., Zhongzheng Dist., Taipei, 10041, Taiwan.
Orphanet J Rare Dis. 2019 Jan 7;14(1):6. doi: 10.1186/s13023-018-0992-2.
Biotinidase deficiency is an autosomal recessive disorder that affects the endogenous recycling and release of biotin from dietary protein. This disease was thought to be rare in East Asia. In this report, we delineate the phenotype of biotinidase deficiency in our cohort. The genotypes and phenotypes of patients diagnosed with biotinidase deficiency from a medical center were reviewed. The clinical manifestations, laboratory findings, and molecular test results were retrospectively analyzed. A total of 6 patients were evaluated. Three patients (50%) were diagnosed because of a clinical illness, and the other three (50%) were identified by newborn screening. In all patients, the molecular results confirmed the BTD mutation. The three patients with clinical manifestations had an onset of seizure at the age of 2 to 3 months. Two patients had respiratory problems (one with apnea under bilevel positive airway pressure (BiPAP) therapy at night, and the other with laryngomalacia). Hearing loss and eye problems were found in one patient. Interestingly, cutaneous manifestations including skin eczema, alopecia, and recurrent fungal infection were less commonly seen compared to cases in the literature. None of the patients identified by the newborn screening program developed symptoms. Our findings highlight differences in the genotype and phenotype compared with those in Western countries. Patients with biotinidase deficiency benefit from newborn screening programs for early detection and management.
生物素酶缺乏症是一种常染色体隐性遗传病,影响膳食蛋白质中生物素的内源性循环和释放。这种疾病被认为在东亚很少见。在本报告中,我们描述了我们队列中生物素酶缺乏症的表型。回顾性分析了从一家医学中心诊断为生物素酶缺乏症的患者的基因型和表型。临床表现、实验室发现和分子检测结果。共评估了 6 名患者。3 名患者(50%)因临床疾病而被诊断,另外 3 名(50%)通过新生儿筛查发现。所有患者的分子结果均证实存在 BTD 突变。有临床表现的 3 名患者在 2 至 3 个月大时出现癫痫发作。2 名患者有呼吸问题(1 名夜间使用双水平气道正压通气(BiPAP)治疗时有呼吸暂停,另 1 名有喉软骨软化症)。1 名患者发现听力损失和眼部问题。有趣的是,与文献中的病例相比,皮肤表现包括湿疹、脱发和复发性真菌感染的发生率较低。新生儿筛查计划中确定的患者均未出现症状。我们的发现强调了与西方国家相比基因型和表型的差异。生物素酶缺乏症患者受益于新生儿筛查计划,以进行早期发现和管理。